您的位置: 首页 > 农业专利 > 详情页

Trans-antigen targeting in heterogeneous cancers and methods of use thereof
专利权人:
The Regents of the University of California
发明人:
LIM, Wendell A.,OKADA, Hideho,ROYBAL, Kole T.,CHOE, Joseph H.,WILLIAMS, Jasper Z.
申请号:
AU2019247830
公开号:
AU2019247830A1
申请日:
2019.04.04
申请国别(地区):
AU
年份:
2020
代理人:
摘要:
Provided are methods of treating a subject for a heterogeneous cancer. The methods of the present disclosure include integrating at least two antigens expressed heterogeneously in the cancer and/or in the cancer microenvironment, including where the antigens are expressed in trans, i.e., expressed by at least two different cell types. The subject methods will generally involve immune cells into which circuits have been introduced that employ one or more binding triggered transcriptional switches and one or more encoded therapeutics specific for antigens expressed by cancer cells and/or by neighboring non-cancer cells. Nucleic acids containing sequences encoding all or portions of such circuits are also provided, as well as cells, expression cassettes and vectors that contain such nucleic acids. Also provided are kits for practicing the described methods.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充